In the last 12 months, insiders at EXOZYMES INC. ($EXOZ) filed 17 transactions with the SEC: 4 open-market purchases totaling $52,997 and 2 sales totaling $15,424. Net insider sentiment: net buying.
EXOZYMES INC. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Opgenorth Paul Hideo (Vice President, Development) — 3 transactions totaling $86,248
- Perriman Damien Alan (Chief Commercial Officer) — 3 transactions totaling $75,006
- Korman Tyler Paz (Chief Scientific Officer) — 3 transactions totaling $60,426
- Heltzen Michael (Chief Executive Officer) — 5 transactions totaling $52,997
- Nawaz Fouad (Vice President- Finance) — 1 transaction totaling $50,632
View all SEC Filings for EXOZYMES INC. (EXOZ).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 8, 2026 | Korman Tyler Paz | Chief Scientific Officer | S | COMMON STOCK | 750 | $10.04 | 729,873.0000 | 8,387,250 | 0.10% | 0.01% |
| April 9, 2026 | Korman Tyler Paz | Chief Scientific Officer | S | COMMON STOCK | 750 | $10.53 | 729,123.0000 | 8,387,250 | 0.10% | 0.01% |
| April 1, 2026 | Perriman Damien Alan | Chief Commercial Officer | A | Restricted Stock Grant for Common Stock | 62759 | $0.00 | 62,759.0000 | 8,387,250 | 9999.99% | 0.75% |
| April 1, 2026 | Korman Tyler Paz | Chief Scientific Officer | A | COMMON STOCK | 5332 | $8.44 | 730,623.0000 | 8,387,250 | 0.74% | 0.06% |
| April 1, 2026 | Nawaz Fouad | Vice President- Finance | A | COMMON STOCK | 5999 | $8.44 | 9,488.0000 | 8,387,250 | 171.94% | 0.07% |
| April 1, 2026 | Perriman Damien Alan | Chief Commercial Officer | A | COMMON STOCK | 8887 | $8.44 | 0.0000 | 8,387,250 | 0.00% | 0.11% |
| April 1, 2026 | Opgenorth Paul Hideo | Vice President, Development | A | COMMON STOCK | 3999 | $8.44 | 645,149.0000 | 8,387,250 | 0.62% | 0.05% |
| April 1, 2026 | Perriman Damien Alan | Chief Commercial Officer | A | Stock Option for Common Stock | 146437 | $0.00 | 146,437.0000 | 8,387,250 | 9999.99% | 1.75% |
| July 2, 2025 | Heltzen Michael | Chief Executive Officer | P | Common Stock | 1040 | $10.22 | 10,628.8000 | 8,367,810 | 10.85% | 0.01% |
| June 17, 2025 | Heltzen Michael | Chief Executive Officer | A | Stock Options for Common Stock | 235817 | $0.00 | 235,817.0000 | 8,367,810 | 9999.99% | 2.82% |
| June 13, 2025 | Nawaz Fouad | Vice President, Finance | A | Common Stock | 3489 | $12.54 | 3,489.0000 | 8,367,810 | 9999.99% | 0.04% |
| June 13, 2025 | Opgenorth Paul Hideo | Vice President, Development | A | Common Stock | 2990 | $12.54 | 641,150.0000 | 8,367,810 | 0.47% | 0.04% |
| June 16, 2025 | Korman Tyler Paz | Vice President, Research | A | Common Stock | 2990 | $12.54 | 725,291.0000 | 8,367,810 | 0.41% | 0.04% |
| Jan. 17, 2025 | Heltzen Michael | Chief Executive Officer | P | Common Stock | 1767 | $10.78 | 3,872.0000 | 8,367,810 | 83.94% | 0.02% |
| Jan. 16, 2025 | Heltzen Michael | Chief Executive Officer | P | Common Stock | 121 | $10.72 | 2,105.0000 | 8,367,810 | 6.10% | 0.00% |
| Nov. 15, 2024 | Heltzen Michael | Chief Executive Officer | P | Common Stock | 1984 | $11.10 | 1,984.0000 | 6,250,002 | 9999.99% | 0.03% |
| Nov. 8, 2024 | Opgenorth Paul Hideo | Vice President, Development | C | Common Stock | 2344 | $6.40 | 640,504.0000 | 6,250,002 | 0.37% | 0.04% |